Rexahn Pharmaceuticals, INC.
SEC CIK 1228627 · RXHN.OB · last insider filing 2026-05-20
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | filed 2024 - 2026 |
| Foundation Fighting Blindness, Inc. | Director | filed 2024 - 2026 |
| Yerxa Benjamin R | Director · President | filed 2024 - 2026 |
| Magrath George | Director · Chief Executive Officer | filed 2023 - 2026 |
| Manuso James S J | Director | filed 2020 - 2026 |
| Rodgers Richard J | Director · Interim CEO and President | filed 2014 - 2026 |
| Graves Adrienne L | Director | filed 2024 - 2026 |
| Benton Susan | Director | filed 2020 - 2026 |
| Gallagher Cam | Director | filed 2020 - 2026 |
| Ainsworth Sean | Director | filed 2020 - 2026 |
| Bennett Jean | Director | filed 2024 - 2026 |
| Pepose Jay | Director | filed 2021 - 2024 |
| Sooch Mina | Director · President and CEO | filed 2020 - 2023 |
| Meyer Alan R | Director | filed 2020 - 2020 |
| Cheong Kwang Soo | Director | filed 2006 - 2019 |
| Beever Charles | Director | filed 2006 - 2019 |
| Price Ben Gil | Director | filed 2018 - 2019 |
| Brandt Peter C. | Director | filed 2010 - 2019 |
| Sullivan Lara | Director | filed 2019 - 2019 |
| Swirsky Douglas J | Director · President and CFO | filed 2018 - 2019 |
| Suzdak Peter David | Director · Chief Executive Officer | filed 2013 - 2018 |
| Carthy Mark | Director | filed 2014 - 2017 |
| Ahn Chang Ho | Director · Chairman & CEO | filed 2006 - 2017 |
| Jeong Tae Heum | Director · Chief Financial Officer | filed 2006 - 2017 |
| Mcintosh David M | Director | filed 2006 - 2014 |
| Hwang Si Moon | Director | filed 2012 - 2014 |
| Kivel Richard | Director | filed 2010 - 2012 |
| Kang Y Michele | Director | filed 2006 - 2009 |
| Hoffman Freddie Ann | Director | filed 2007 - 2009 |
| Park Young Soon | Director | filed 2006 - 2007 |
| Ahn Inok | Director | filed 2006 - 2006 |
| Holaday John W DR | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Schachle Joseph K | Chief Operating Officer | filed 2023 - 2026 |
| Gagnon Robert E. | Chief Financial Officer | filed 2025 - 2026 |
| Zaremba Rabourn Amy | VP of Finance | filed 2020 - 2026 |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | filed 2024 - 2026 |
| Hoffmann Bernhard | VP of Corp. Dev. and Secretary | filed 2020 - 2025 |
| Jhaveri Nirav S. | Chief Financial Officer | filed 2024 - 2025 |
| Patel Ronil A. | SVP, Operations & Bus. Dev. | filed 2023 - 2024 |
| Benaim Ely | Chief Medical Officer | filed 2015 - 2019 |
| Nolan Lisa | Chief Business Officer | filed 2016 - 2019 |
| Soni Rakesh | President and COO | filed 2008 - 2014 |
| Steinfels George F | Chief Business Officer Sr. VP | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.